SCHEMBL5604458

SCHEMBL5604458

COc1ccccc1NC(=O)NCc1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.76
HDAC6 Q9UBN7 2/20 0.76
POLB P06746 1/20 0.74
HDAC11 Q96DB2 1/20 0.74
GAA P10253 2/20 0.68
KDM4E B2RXH2 2/20 0.68
ALDH1A1 P00352 1/20 0.68
TP53 P04637 2/20 0.67
CFD P00746 1/20 0.61
KMT2A Q03164 2/20 0.61
MEN1 O00255 1/20 0.61
NAMPT P43490 1/20 0.61
GSK3B P49841 1/20 0.60
GLA P06280 1/20 0.60
HPGD P15428 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.59
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
SNCA P37840 1/20 0.58
PTPN1 P18031 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28750716 0.89 HDAC1 (0.77) HDAC1HDAC6POLBHDAC11GAA
SCHEMBL11615022 0.89 NAMPT (0.77) HDAC1HDAC6POLBHDAC11ALDH1A1
SCHEMBL18415564 0.87 MAPT (0.67) HDAC1HDAC6POLBHDAC11KDM4E
SCHEMBL16442075 0.86 HDAC1 (1.00) HDAC1HDAC6POLBHDAC11GAA
SCHEMBL15289681 0.85 HDAC1 (1.00) HDAC1HDAC6POLBHDAC11GAA
SCHEMBL10172937 0.83 GAA (0.65) HDAC1HDAC6POLBHDAC11GAA
SCHEMBL15575211 0.82 ALDH1A1 (0.66) HDAC1HDAC6POLBHDAC11GAA
SCHEMBL20027144 0.82 RAB9A (0.80) POLBGAAKDM4EHPGDRAB9A
SCHEMBL31040567 0.82 POLB (0.77) POLBGAAKDM4EALDH1A1KMT2A
SCHEMBL4554983 0.82 POLB (0.77) POLBGAAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019182527-A1 METHYL JASMONATE DERIVATIVES AS POSSIBLE DRUG CANDIDATES FOR USE IN TREATMENT OF CANCER T.C. ISTANBUL MEDIPOL UNIVERSITESI (TR) 2019-09-26 WO disclosed
EP-1390340-B1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2017-03-01 EP disclosed
EP-1390340-B1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2017-03-01 EP disclosed
CN-103664704-B A kind of synthetic N, the method for N '-disubstituted urea NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2016-05-18 CN disclosed
US-9067955-B2 Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-06-30 US disclosed
US-9067955-B2 Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-06-30 US disclosed
CN-103664704-A Method for synthesizing N,N'-disubstituent urea UNIV NANJING SCIENCE & TECH 2014-03-26 CN disclosed
EP-1390340-A4 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2007-07-25 EP disclosed
US-20060264673-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-11-23 US disclosed
US-7115784-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-10-03 US disclosed
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-09-29 US disclosed
US-6867298-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2005-03-15 US disclosed
CN-1518534-A Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation 麻省理工学院 2004-08-04 CN disclosed
US-6759554-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-07-06 US disclosed
EP-1390340-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-02-25 EP disclosed
US-20030065187-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-04-03 US disclosed
WO-2002085838-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264673-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds ADH5, CBR3, ALDH3A1 HDAC1 1029/4885HDAC6 979/4885POLB 3522/4885
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds CBR3, ADH5, IDH1 HDAC1 1010/4885HDAC6 944/4885POLB 3503/4885
US-20030065187-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds ADH5, CBR3, ALDH3A1 HDAC1 1029/4885HDAC6 979/4885POLB 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.